Skip to content
Application 204876
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | BIVALIRUDIN | BIVALIRUDIN | INJECTABLE;INTRAVENOUS | 250MG/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 60505-6101 | Bivalirudin | bivalirudin | Apotex corp | ANDA | Current |
| 60505-6101 | Bivalirudin | bivalirudin | Apotex corp | ANDA | Current |
| 60505-6101 | Bivalirudin | bivalirudin | Apotex corp | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 48943 | ORIG | 2017-07-11 |